HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Fear Possible Faith-Based Access Restrictions
Some advocacy groups are urging regulators not to waive a merger review of Irvine-based St. Joseph Health and Renton, Wash.-based Providence Health and Services’ proposed mega-affiliation.
University of California-Irvine today named Dr. Howard Federoff chief executive of UC Irvine Health.
Irvine-based Axonics Modulation Technologies Inc. raised $38.5 million in Series B financing.
Orange County entrepreneurs received more than $529 million in venture capital spread across 12 deals in the fourth quarter, said Dow Jones VentureSource.
Avanir Pharmaceuticals Inc., an Aliso Viejo-based drugmaker, said today that Rohan Palekar is its new chief executive.
San Clemente-based VertiFlex Inc. has raised $26.8 million out of a proposed $45.7 million in funding, according to a Securities and Exchange Commission filing.
Newport Beach-based Strathspey Crown Holdings LLC bought the portfolio companies of Incline Village, Nevada-based Novus Via LP on undisclosed terms.
Kenneth McFarland, chief executive of Mission Hospital, said today that he will leave to pursue other opportunities. McFarland’s departure is effective Feb. 5.
Children’s Hospital of Orange County has bought an eight-story medical and office building next to its main campus in Orange.
Aliso Viejo-based medical device maker Ellipse Technologies Inc. will be sold to San Diego-based NuVasive Inc. in a deal worth up to $410 million.
Irvine-based healthcare facilities operator Silverado named Shamim Wu president and chief operating officer, a new position.
Kaiser Permanente plans to open a medical school in Southern California.
Edwards Lifesciences Corp. in Irvine has invested in Harpoon Medical Inc., a Baltimore-based start-up company developing a “minimally invasive” product to surgically repair mitral valves in the heart.
Irvine-based Alphaeon Corp. has named former New Mexico governor Bill Richardson and James Xiaodong Liu, chief executive of Hong Kong-based Sailing Capital Management to its board of directors.
Chase Pharmaceuticals Corp. said that it has appointed Douglas Ingram, a former president of Allergan Inc., which was based in Irvine, as its chief executive.